Johnson & Johnson (JNJ) Stock Forecast for 2024–2028. Sell or Buy Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Johnson & Johnson (JNJ) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 13, 2024 (06:22)

Sector: Healthcare

The share price of Johnson & Johnson (JNJ) now

Latest session on the 12th of April for
Johnson & Johnson is negative
Trading Volume: 7100178
Open: 148.06 /  High: 149.065 /  Low: 147.15
What analysts predict: $176.22
52-week High/Low: $173.31 / $143.8

50/200 Day Moving Average: $158.16 / $159.27

This figure corresponds to the Average Price over the previous 50/200 days. For Johnson & Johnson stocks, the 50-day moving average is the resistance level today.

For Johnson & Johnson stocks, the 200-day moving average is the resistance level today.

Are you interested in Johnson & Johnson stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Johnson & Johnson stock price in 2024, 2025, 2026, 2027, 2028. How much will one Johnson & Johnson share be worth in 2024 - 2028?

When should I take profit in Johnson & Johnson stock? When should I record a loss on Johnson & Johnson stock? What are analysts' forecasts for Johnson & Johnson stock? What is the future of Johnson & Johnson stock? We forecast Johnson & Johnson stock performance using neural networks based on historical data on Johnson & Johnson stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Johnson & Johnson stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Johnson & Johnson shares. This happens once a day.


Historical and forecast chart of Johnson & Johnson stock

The chart below shows the historical price of Johnson & Johnson stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Johnson & Johnson stock price can be found in the table below.

Long-term forecasts by years.

Unlocking the Future of JNJ Stocks: A Comprehensive Forecast

Trend: Strong Bullish
Apr 12, 2024

When it comes to prognosticating the trajectory of Johnson & Johnson's (JNJ) stock, a trio of factors emerges as pivotal. The meticulous consideration of these determinants provides a compass for analysts aiming to furnish the most informed Johnson & Johnson stock forecast. At the heart of JNJ’s future stock performance lie its robust financials, an unwavering dividend policy, and the prospective uptick in healthcare spending.

The Pillars of Prediction: Key JNJ Stock Influencers

JNJ’s financial solidity, evidenced by its impressive sales and earnings growth across its Innovative Medicine and MedTech segments, stands out as a critical driver. Analysts leveraging this data can offer a bullish JNJ stock forecast, emphasizing the company’s adeptness at capital allocation and its implications for stock price appreciation.

Moreover, Johnson & Johnson’s distinction in consistently raising dividends over 61 years cannot be underestimated. This enviable record, paired with a 3% dividend yield, bolsters its image as a stable investment, potentially influencing a positive JNJ stock price prediction. The attractiveness to income-focused investors is clear, adding a layer of predictability amidst volatile markets.

Lastly, the evolving landscape of healthcare spending is set to favor JNJ. As a leader in healthcare innovation, Johnson & Johnson is positioned to capitalize on increased expenditures in this sector. For analysts, this represents a tangible parameter to include in a JNJ stock price target, forecasting the company's growth potential in an expanding market.

In summary, by synthesizing insights on financial performance, dividend reliability, and healthcare spending trends, market analysts can craft a well-rounded JNJ stock buy or sell recommendation. Through such a lens, the question of 'is JNJ a good stock to buy?' gets a nuanced analysis, offering investors a clearer picture of the stock’s promising future.

Review the original Analysis
About author

Unlocking the Future of JNJ Stocks: What's Next?

Trend: Bullish
Apr 11, 2024

Investors eyeing the Johnson & Johnson (JNJ) stock forecast have a lot on their plate. With an assortment of factors at play, making savvy predictions on whether to classify JNJ stocks as a buy or sell has never been more engaging. Key events poised to shape the trajectory of JNJ stock rates include an anticipated robust earnings performance, a potential dividend increase, the strategic acquisition of Shockwave Medical, and the looming shadow of litigation concerns.

Deciphering the Signals: A Guide to JNJ's Stock Prospects

Analysts keen on crafting an accurate JNJ stock price prediction would do well to closely monitor these influences. The company's record of consistently outperforming earnings estimates suggests a resilient financial health that may significantly buoy the JNJ stock price target. Furthermore, JNJ’s historical penchant for rewarding shareholders through regular dividend increases is expected to continue, marking its 62nd consecutive dividend hike - a fact that sings volumes of its financial fortitude and appeals magnetically to income investors.

On the acquisitions front, JNJ's recent uptake of Shockwave Medical stands out as a strategic addition to its cardiovascular portfolio. Although tagged with high valuation multiples, this move is anticipated to inject fresh vitality into JNJ's MedTech segment, underscoring the company's adeptness at navigating the acquisition landscape. Nonetheless, it's crucial not to overlook the dark cloud of talc litigation and the anxiety over the expiry of pharmaceutical patents, which pose palpable threats to JNJ's stock forecast.

Given these dynamics, is JNJ a good stock to buy? For those plotting JNJ’s stock price prediction, weaving through these factors with a keen eye on the company’s robust earnings profile, history of dividend generosity, strategic acquisitions, and litigation outcomes offers the clearest vantage point for making informed decisions on whether to buy or sell Johnson & Johnson stock.

Review the original Analysis
About author

Unlocking the Future: Predicting JNJ Stock Movement with Precision

Trend: Neutral
Apr 04, 2024

Predicting the stock forecast for Johnson & Johnson (JNJ) has become akin to deciphering a sophisticated puzzle. Among the myriad factors, there are a few potent ones poised to shape the fate of JNJ stocks significantly. Analysts gearing up for the most accurate JNJ stock price prediction are closely watching patent expirations, fierce competition, unfolding lawsuits, and the ambitious revenue growth projections set by the company.

Crucial Factors Guiding JNJ Stock Predictions

The imminent expiration of patents for blockbuster drugs like Stelara opens a gate of uncertainty, potentially leading to a notable dip in revenue. This situation offers a critical insight for those contemplating whether JNJ is a good stock to buy, as the company's ability to innovate and replenish its drug pipeline is key. Moreover, with around 50,000 lawsuits related to its talc powder alleging cancer links, the financial repercussions and reputational damage could sway the JNJ stock forecast considerably.

Intense competition in areas such as oncology and immunology also plays a decisive role. Analysts keen on making a relevant JNJ stock price target must gauge how well JNJ can navigate this battlefield compared to its rivals. The ambitious 5-7% revenue growth target for 2025-2030 dares to redefine expectations. Achieving this would not only revitalize trust but possibly mark JNJ stock as a buy.

Arranged in order of their impactful capacity, the pecking order starts with competition, followed by patent expirations, litigation outcomes, and finally, revenue projections. These elements combined, offer a comprehensive approach for anyone wrestling with the question of whether to buy or sell Johnson & Johnson stock. In answering this, the inherent dynamics between these factors become the cornerstone for any informed JNJ stock price prediction.

Review the original Analysis
About author

If you’re shopping around for top-notch dividend kings to invest in, consider placing Johnson & Johnson (NYSE:JNJ) at the top of your list. For over six decades, this US pharmaceutical titan has been consistently boosting its dividends and currently gifts investors with a quarterly dividend of $1.19 per share. On September 23, it recorded a pretty decent dividend yield of 2.97%.

Recent data suggests that the popularity of Johnson & Johnson (NYSE:JNJ) among hedge funds is on the rise. At the end of Q2 2023, it held a spot in the portfolios of 88 hedge funds, a slight jump from 86 during the previous quarter. What makes this even more significant is that these stakes tally up to a value north of $4.1 billion!

Johnson & Johnson manufactures hygiene products, first aid medicines and medical equipment. Compeed adhesive plasters, Johnson’s Baby care for children, Neutrogena cosmetics, Clean & Clear cleansers and Acuvue contact lenses are the company’s products.

The holding includes 250 companies with three areas of activity: pharmaceuticals, consumer goods and medical equipment manufacturing. Johnson & Johnson products are sold in 175 countries. In 2016, the company earned $ 71.9 billion.

The Johnson brothers originally produced sterile surgical dressings. The first batch went on sale in 1886. Johnson & Johnson’s dressings grew in popularity and were safe and ready to use. In 1916 Johnson & Johnson bought the first textile manufactory. By 1919, the brothers had established a subsidiary in Canada, and by 1924 in the UK. In 1927, the company produced baby cosmetics, feminine hygiene products and adhesive plasters.

Official site of the company

Johnson & Johnson daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 15 149.96 149.20 150.71 1.01
Apr 16 149.99 149.09 151.34 1.51
Apr 17 148.86 148.37 149.42 0.71
Apr 18 147.50 146.99 149.20 1.51
Apr 19 149.16 147.84 150.30 1.66
Apr 20 149.79 148.98 151.16 1.46
Apr 21 149.99 149.11 151.20 1.40
Apr 22 149.43 148.78 150.37 1.07
Apr 23 147.68 146.28 148.56 1.56
Apr 24 146.84 146.15 148.60 1.67
Apr 25 147.58 146.28 149.07 1.91
Apr 26 149.42 148.19 149.98 1.21
Apr 27 150.72 149.07 152.28 2.15
Apr 28 150.90 149.18 151.49 1.55
Apr 29 150.31 148.78 150.76 1.33
Apr 30 152.23 150.56 152.78 1.47
May 01 154.33 152.78 155.35 1.68
May 02 154.56 152.82 156.21 2.21
May 03 153.82 153.04 155.53 1.63
May 04 152.07 150.88 152.68 1.19
May 05 152.43 151.54 154.12 1.70
May 06 151.65 149.86 152.72 1.91
May 07 152.79 151.76 153.25 0.98
May 08 154.99 153.55 156.06 1.64
May 09 156.32 154.70 158.08 2.18
May 10 157.89 157.34 159.14 1.14
May 11 156.82 154.96 157.53 1.65
May 12 155.29 154.11 156.37 1.47
May 13 156.25 154.58 156.93 1.52
May 14 155.48 153.84 156.34 1.62

Johnson & Johnson Daily Price Targets


Johnson & Johnson Stock Forecast 04-15-2024.

Forecast target price for 04-15-2024: $149.96.
Positive dynamics for Johnson & Johnson shares will prevail with possible volatility of 1.000%.
Pessimistic target level: 149.20
Optimistic target level: 150.71

Johnson & Johnson Stock Forecast 04-16-2024.

Forecast target price for 04-16-2024: $149.99.
Positive dynamics for Johnson & Johnson shares will prevail with possible volatility of 1.487%.
Pessimistic target level: 149.09
Optimistic target level: 151.34

Johnson & Johnson Stock Forecast 04-17-2024.

Forecast target price for 04-17-2024: $148.86.
Negative dynamics for Johnson & Johnson shares will prevail with possible volatility of 0.702%.
Pessimistic target level: 148.37
Optimistic target level: 149.42

Johnson & Johnson Stock Forecast 04-18-2024.

Forecast target price for 04-18-2024: $147.50.
Negative dynamics for Johnson & Johnson shares will prevail with possible volatility of 1.483%.
Pessimistic target level: 146.99
Optimistic target level: 149.20

Johnson & Johnson Stock Forecast 04-19-2024.

Forecast target price for 04-19-2024: $149.16.
Positive dynamics for Johnson & Johnson shares will prevail with possible volatility of 1.637%.
Pessimistic target level: 147.84
Optimistic target level: 150.30

Johnson & Johnson Stock Forecast 04-20-2024.

Forecast target price for 04-20-2024: $149.79.
Positive dynamics for Johnson & Johnson shares will prevail with possible volatility of 1.442%.
Pessimistic target level: 148.98
Optimistic target level: 151.16

JNJ (JNJ) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 152.74 151.03 155.71 3.00
Jun. 151.58 149.51 153.71 2.73
Jul. 149.18 147.35 152.40 3.31
Aug. 144.19 140.60 147.82 4.88
Sep. 139.46 137.15 140.82 2.60
Oct. 140.07 138.96 143.75 3.33
Nov. 144.65 141.22 147.36 4.17
Dec. 143.46 140.93 146.40 3.74

Johnson & Johnson forecast for this year


Johnson & Johnson Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $152.736. Pessimistic: $151.03. Optimistic: $155.71


Johnson & Johnson Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $151.581. Pessimistic: $149.51. Optimistic: $153.71


Johnson & Johnson Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $149.18. Pessimistic: $147.35. Optimistic: $152.40


Johnson & Johnson Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $144.186. Pessimistic: $140.60. Optimistic: $147.82


Johnson & Johnson Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $139.462. Pessimistic: $137.15. Optimistic: $140.82


Johnson & Johnson Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $140.065. Pessimistic: $138.96. Optimistic: $143.75


Johnson & Johnson Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $144.653. Pessimistic: $141.22. Optimistic: $147.36


Johnson & Johnson Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $143.455. Pessimistic: $140.93. Optimistic: $146.40



Johnson & Johnson (JNJ) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 145.83 143.31 147.67 2.95
Feb 141.26 137.81 142.54 3.32
Mar 141.93 140.90 145.50 3.16
Apr 139.73 135.75 142.49 4.73
May 144.31 141.45 148.05 4.46
Jun 143.73 139.65 146.84 4.90
Jul 144.15 142.64 147.73 3.44
Aug 145.60 141.93 148.38 4.34
Sep 149.74 146.18 153.03 4.47
Oct 152.76 151.06 155.57 2.90
Nov 153.75 152.15 156.24 2.62
Dec 156.30 152.41 157.59 3.29

Johnson & Johnson (JNJ) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 151.35 148.78 153.20 2.88
Feb 151.73 148.61 155.88 4.66
Mar 150.91 147.76 153.79 3.92
Apr 151.45 147.80 154.40 4.27
May 154.89 150.98 158.62 4.82
Jun 156.89 154.29 160.62 3.94
Jul 161.36 159.79 163.39 2.20
Aug 161.12 159.38 162.63 2.00
Sep 155.96 152.70 158.26 3.51
Oct 155.40 152.27 158.53 3.95
Nov 156.63 152.68 160.75 5.02
Dec 156.29 153.42 159.16 3.61

Johnson & Johnson (JNJ) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 154.66 151.71 157.33 3.57
Feb 156.94 153.95 158.81 3.06
Mar 154.57 151.40 158.08 4.22
Apr 155.52 152.27 159.99 4.83
May 157.47 156.00 160.71 2.93
Jun 156.85 153.75 160.30 4.09
Jul 154.20 151.75 156.31 2.91
Aug 154.31 149.98 156.25 4.02
Sep 155.97 154.29 159.29 3.14
Oct 154.18 152.73 158.51 3.64
Nov 153.35 150.75 155.33 2.95
Dec 151.58 150.16 155.40 3.37

Johnson & Johnson (JNJ) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 155.73 153.93 157.74 2.42
Feb 157.24 153.39 159.16 3.63
Mar 156.90 154.36 158.43 2.57
Apr 158.99 155.67 161.79 3.79
May 158.42 156.19 160.41 2.63
Jun 155.79 151.36 159.33 5.00
Jul 154.28 151.06 157.89 4.33
Aug 155.89 153.42 158.30 3.08
Sep 154.99 152.09 156.50 2.82
Oct 150.42 146.09 151.83 3.78
Nov 152.31 149.52 154.01 2.92
Dec 154.73 151.55 158.51 4.39

Johnson & Johnson information and performance

Johnson & Johnson Address

ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, US

Market Capitalization: 367 226 356 000 $

Market capitalization of the Johnson & Johnson is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of JNJ shares in the company outstanding by the market price of one share.

EBITDA: 30 767 000 000 $

EBITDA of Johnson & Johnson is earnings before interest, income tax and depreciation of assets.

PE Ratio: 29.31

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.935

Price/earnings to growth

DPS: 4.7

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0312

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 5.2

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.106
Quarterly Revenue Growth YOY: 0.073
Trailing PE: 29.31

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.31

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.388

Enterprise Value (EV) /Revenue

EV To EBITDA: 16.02

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 2409780000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Johnson & Johnson (JNJ) stock dividend

Johnson & Johnson last paid dividends on 02/16/2024. The next scheduled payment will be on 03/05/2024. The amount of dividends is $4.7 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.